AiPlex^® CD

IVDR-CE Mark Celiac Disease Microarray Solution for the MosaiQ Platform

Designed to provide comprehensive CD diagnostic insights & workflow efficiency.

Celiac Disease: A global challenge

Celiac disease is a chronic digestive and immune
disorder, found in genetically predisposed individuals, triggered by gluten ingestion, affecting the small intestine with a global prevalence of 1 in 100^1. The diagnosis is often challenging due to a wide range of overlapping symptoms.

Current diagnostic tests include antibodies against tTG, DGP, as well as Total IgA and sometimes EMA (IFA). IgA is the isotope of choice, however, IgG is requested knowing the prevalence of Total IgA deficiency.

Fast, Easy, Comprehensive

AliveDx planar microarray supporting celiac disease diagnosis, AiPlex CD, is designed to deliver rapid in-vitro test results, helping to reduce the time to results for patients. The panel combines both IgA and IgG, providing a comprehensive analysis in every sample.

Designed to provide comprehensive CD diagnostic insights and workflow efficiency

AiPlex CD microarray contains key markers recommended by clinical guidelines American College of Gastroenterology (ACG) and the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) and the European Society for the Study of Coeliac Disease (ESsCD).

Following guidelines (ESsCD), especially for pediatric population anti-tTG IgA results may help determine the need for an invasive procedure (no-biopsy diagnosis) based on the provided ULN (upper limit of normal). In case of IgA deficiency, testing for IgG autoantibodies are recommended.

Multiple insights in one report with only 20µl patient sample. One microarray provides up to 4 individual results.
Saves valuable time while avoiding human errors with a standardized master curve embedded into RFID² tags, included with all reagents and microarrays.
Reduces hands-on time and storage space with ready for use, concentrated onboard reagents and buffers.
Provides insights on Total IgA measurement and values in AU/ml for anti-tTG and anti-DGP for both IgA and IgG.

AiPlex CD for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with Celiac Disease

Simple Workflow

Patients sample in, result out in one single step
QC and calibration embedded

Fast Results

Results within one day
One low-volume sample tube for multiple tests

Actionable Insights

Panels help streamline clinical decision-making for physicians
Comprehensive panels simplify complex testing pathways

Learn more about our MosaiQ solution and our menu:

MosaiQ Solution LumiQ AiPlex CTDplus AiPlex CTD ALLERGYPLEX

How can the MosaiQ AiPlex CD assay benefit your lab?

¹Rubio-Tapia A et al. Am J Gastroenterol. 2023;118(1):59-76.
²Radio Frequency Identification.

© AliveDx Suisse SA, 2024. The AliveDx logo, AliveDx, MosaiQ AiPlex, AiPlex and MosaiQ are trademarks or registered trademarks of AliveDx group companies in various jurisdictions. Menus and capabilities are subject to change. Not all methods may be available in all territories. For CE- Mark accepting regions and subject to clearance in other territories.

AiPlex® CD